NCT04794127
- Conditions
- Liposarcoma, Liposarcoma, Dedifferentiated, Liposarcoma, Myxoid, +6 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale Tumori Milan, MI, Italy
Clinical trial condition
Liposarcoma, Myxoid
Explore clinical trials studying Liposarcoma, Myxoid. Study availability and eligibility vary by location and protocol.
22 public trials
8 recruiting studies
Liposarcoma, Myxoid trial results
NCT03063632
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +33 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT03450122
- Conditions
- HLA-A*0201 Positive Cells Present, Liposarcoma, Liposarcoma, Myxoid, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02992743
- Conditions
- Liposarcoma, Liposarcoma, Myxoid, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Tampa, Florida, United States
- GSK Investigational Site Ann Arbor, Michigan, United States
- GSK Investigational Site St Louis, Missouri, United States
- GSK Investigational Site New York, United States
Completed
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
NCT02821507
- Conditions
- Chondrosarcoma, Chondrosarcoma, Mesenchymal, Conventional Chondrosarcoma, +11 more
- Locations
-
- LUMC Leiden, Netherlands
- Hospital de Sant Pau Barcelona, Spain
- Hospital Val d'Hebron Barcelona, Spain
- CIO Clara Campal Madrid, Spain
NCT04512495
- Conditions
- Leiomyosarcoma, Liposarcoma, Liposarcoma, Myxoid, +11 more
- Locations
-
- Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France
NCT00579501
- Conditions
- Liposarcoma, Liposarcoma, Myxoid, Liposarcoma,Myxoid, +5 more
- Locations
-
- Coeur d'Alene, Idaho, United States
- Park Ridge, Illinois, United States
- Iowa City, Iowa, United States
- Boston, Massachusetts, United States
Active, Not Recruiting
BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
NCT06414434
- Conditions
- CIC-Rearranged Sarcoma, Liposarcoma, Liposarcoma, Myxoid, +10 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
MAGE-A4ᶜ¹º³²T for Multi-Tumor
NCT03132922
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
- Locations
-
- University of Miami Miami, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Washington University St Louis, Missouri, United States
Active, Not Recruiting
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
NCT03967223
- Conditions
- Liposarcoma, Liposarcoma, Myxoid, Neoplasms, +6 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Hospital and Clinics Stanford, California, United States
- Sarah Cannon Research Institute Denver, Colorado, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States